Maverick Capital’s Amgen AMGN Stock Holding History

Maverick Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,882	Closed	-$506K	–	356
2023 Q3	$506K	Buy	+1,882	New	+$470K	0.01%	178
2021 Q3	–	Sell	-1,670	Closed	-$407K	–	636
2021 Q2	$407K	Buy	1,670 +1,561	+1,432%	+$384K	﹤0.01%	407
2021 Q1	$27K	Buy	+109	New	+$26K	﹤0.01%	660
2019 Q4	–	Sell	-4,862	Closed	-$941K	–	345
2019 Q3	$941K	Buy	+4,862	New	+$933K	0.01%	289
2017 Q3	–	Sell	-10,200	Closed	-$1.76M	–	180
2017 Q2	$1.76M	Buy	10,200 +6,420	+170%	+$1.04M	0.02%	150
2017 Q1	$620K	Sell	3,780 -790	-17%	-$131K	0.01%	126
2016 Q4	$668K	Buy	4,570 +940	+26%	+$141K	0.01%	111
2016 Q3	$606K	Sell	3,630 -310	-8%	-$52.4K	0.01%	120
2016 Q2	$599K	Buy	3,940 +480	+14%	+$74.6K	0.01%	117
2016 Q1	$519K	Buy	3,460 +1,780	+106%	+$264K	0.01%	112
2015 Q4	$273K	Hold	1,680	–	–	﹤0.01%	94
2015 Q3	$232K	Hold	1,680	–	–	﹤0.01%	108
2015 Q2	$258K	Buy	1,680 +110	+7%	+$17.6K	﹤0.01%	90
2015 Q1	$251K	Buy	+1,570	New	+$247K	﹤0.01%	104

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Maverick Capital's AMGN Position: Q4 2023 in Review

Maverick Capital sold out of Amgen (AMGN) in Q4 2023, closing a stake of 1,882 shares — an estimated $506K sold.

Maverick Capital first reported a position in AMGN in Q1 2015 and held it in 14 quarters. The position peaked at $1.76M in Q2 2017. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

Maverick Capital reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
Maverick Capital sold 1,882 Amgen shares in Q4 2023, an estimated $506K.
Maverick Capital first reported a position in Amgen in Q1 2015 and held it in 14 quarters.
Maverick Capital's Amgen position peaked at $1.76M in Q2 2017.
2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Maverick Capital's 13F filing for Q4 2023, filed 14 Feb 2024.